MRI may replace needle biopsy for muscle disease diagnosis
NCT ID NCT01432613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether whole body MRI can accurately diagnose inflammatory myopathies—a group of muscle diseases causing weakness and damage. Researchers compared MRI results with muscle biopsies in 139 people suspected of having these conditions. If MRI proves reliable, it could offer a less invasive way to diagnose these serious diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, MRI could become a reliable, non-invasive tool to diagnose inflammatory myopathies faster and more accurately.
- What could go wrong
- This is a completed diagnostic accuracy study, not a treatment trial. MRI may not replace biopsy entirely, and results depend on patient selection and MRI quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens Nord
Amiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can a targeted immune drug calm rare muscle inflammation?
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Engineered immune cells take aim at childhood autoimmune diseases
- New study aims to unlock secrets of rare muscle disease